×
About 1,423 results

ALLMedicine™ Anaplastic Thyroid Carcinoma Center

Research & Reviews  697 results

The role of carbon nanoparticle in lymph node detection and parathyroid gland protectio...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654818
PloS One; Xu S, Li Z et. al.

Nov 10th, 2020 - To assess the efficiency of the carbon nanoparticles (CNs) in lymph node identification and parathyroid gland (PG) protection during thyroidectomy for non-anaplastic thyroid carcinoma (N-ATC). A systematic literature search for relevant literature...

Rechallenge with dabrafenib plus trametinib in anaplastic thyroid cancer: A case report...
https://doi.org/10.1016/j.currproblcancer.2020.100668
Current Problems in Cancer; Arıkan R, Telli TA et. al.

Oct 31st, 2020 - Anaplastic thyroid carcinoma (ATC) is a highly aggressive, undifferentiated rare tumor. Median overall survival is usually between 8 and10 months, with a 1-year survival rate of 20%. Conventional anthracycline based chemotherapy regimens demonstra...

A long survival patient of anaplastic thyroid carcinoma treated with lenvatinib.
https://doi.org/10.1016/j.anl.2020.10.005
Auris, Nasus, Larynx; Hamamoto T, Kono T et. al.

Oct 28th, 2020 - Anaplastic thyroid carcinoma (ATC) accounts for 1-2% of all malignant thyroid tumors. There are only a small number of patients with ATC and most of them die within 6 months after diagnosis, making it difficult to establish a standard treatment st...

Detection of STRN-ALK fusion in thyroid nodules with indeterminate cytopathology facili...
https://doi.org/10.1002/dc.24647
Diagnostic Cytopathology REFERENCES; Jurkiewicz M, Cimic A et. al.

Oct 21st, 2020 - Thyroid cancer is the most common endocrine malignancy. Approximately 70% of cases of papillary thyroid carcinoma and 50% of poorly differentiated and anaplastic thyroid carcinoma harbor well-characterized driver mutations and chromosomal rearrang...

Anaplastic thyroid carcinoma combined with sclerosing mucoepidermoid carcinoma with eos...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7572036
Medicine Mao R, Shi L et. al.

Oct 21st, 2020 - Anaplastic thyroid carcinoma (ATC) is a rare highly aggressive thyroid malignancy. Thyroid sclerosing mucoepidermoid carcinoma with eosinophilia is also a rare low grade malignant thyroid neoplasm. To date, comorbidity of these 2 tumors in the thy...

see more →

Guidelines  2 results

American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid C...
https://www.liebertpub.com/doi/10.1089/thy.2012.0302
Robert C. Smallridge

Nov 5th, 2012 - These are the first comprehensive guidelines for ATC and provide recommendations for management of this extremely aggressive malignancy. Patients with stage IVA/IVB resectable disease have the best prognosis, particularly if a multimodal approach.

The revised clinical practice guidelines on the management of thyroid tumors by the Japan Associations of Endocrine Surgeons: Core questions and recommendations for treatments of thyroid cancer
https://www.jstage.jst.go.jp/article/endocrj/advpub/0/advpub_EJ20-0025/_pdf/-char/en
Endocrine Journal;

 The Japan Associations of Endocrine Surgeons has developed the revised version of the Clinical Practice Guidelines for Thyroid Tumors. This article describes the guidelines translated into English for the 35 clinical questions relevant to the t...

see more →

Clinicaltrials.gov  713 results

The role of carbon nanoparticle in lymph node detection and parathyroid gland protectio...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654818
PloS One; Xu S, Li Z et. al.

Nov 10th, 2020 - To assess the efficiency of the carbon nanoparticles (CNs) in lymph node identification and parathyroid gland (PG) protection during thyroidectomy for non-anaplastic thyroid carcinoma (N-ATC). A systematic literature search for relevant literature...

Rechallenge with dabrafenib plus trametinib in anaplastic thyroid cancer: A case report...
https://doi.org/10.1016/j.currproblcancer.2020.100668
Current Problems in Cancer; Arıkan R, Telli TA et. al.

Oct 31st, 2020 - Anaplastic thyroid carcinoma (ATC) is a highly aggressive, undifferentiated rare tumor. Median overall survival is usually between 8 and10 months, with a 1-year survival rate of 20%. Conventional anthracycline based chemotherapy regimens demonstra...

A long survival patient of anaplastic thyroid carcinoma treated with lenvatinib.
https://doi.org/10.1016/j.anl.2020.10.005
Auris, Nasus, Larynx; Hamamoto T, Kono T et. al.

Oct 28th, 2020 - Anaplastic thyroid carcinoma (ATC) accounts for 1-2% of all malignant thyroid tumors. There are only a small number of patients with ATC and most of them die within 6 months after diagnosis, making it difficult to establish a standard treatment st...

Detection of STRN-ALK fusion in thyroid nodules with indeterminate cytopathology facili...
https://doi.org/10.1002/dc.24647
Diagnostic Cytopathology REFERENCES; Jurkiewicz M, Cimic A et. al.

Oct 21st, 2020 - Thyroid cancer is the most common endocrine malignancy. Approximately 70% of cases of papillary thyroid carcinoma and 50% of poorly differentiated and anaplastic thyroid carcinoma harbor well-characterized driver mutations and chromosomal rearrang...

Anaplastic thyroid carcinoma combined with sclerosing mucoepidermoid carcinoma with eos...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7572036
Medicine Mao R, Shi L et. al.

Oct 21st, 2020 - Anaplastic thyroid carcinoma (ATC) is a rare highly aggressive thyroid malignancy. Thyroid sclerosing mucoepidermoid carcinoma with eosinophilia is also a rare low grade malignant thyroid neoplasm. To date, comorbidity of these 2 tumors in the thy...

see more →

News  11 results

Targeted Treatment Tied to Longer Survival in Patients With Anaplastic Thyroid Cancer
https://www.medscape.com/viewarticle/936044

Aug 20th, 2020 - NEW YORK (Reuters Health) - With the introduction of targeted treatments for anaplastic thyroid carcinoma, patients have seen significant improvements in survival, according to a new report. "Over the last 5 years, a greater understanding of the m...

Targeted Treatment Tied to Longer Survival in Patients With Anaplastic Thyroid Cancer
https://www.staging.medscape.com/viewarticle/936044

Aug 20th, 2020 - NEW YORK (Reuters Health) - With the introduction of targeted treatments for anaplastic thyroid carcinoma, patients have seen significant improvements in survival, according to a new report. "Over the last 5 years, a greater understanding of the m...

Lichenoid dermatitis with mycosis fungoides features linked to checkpoint inhibitor therapy
https://www.mdedge.com/hematology-oncology/article/205419/immunotherapy/lichenoid-dermatitis-mycosis-fungoides-features?channel=39313
Bianca Nogrady

Jul 28th, 2019 - A patient treated with immune checkpoint inhibitor therapy for thyroid carcinoma presented with lichenoid dermatitis that resembled mycosis fungoides and also showed with monoclonal T-cell receptor gene rearrangement. A case report published in th.

Aggressive Approach to Anaplastic Thyroid Cancer Shows Benefit
https://www.medscape.com/viewarticle/852901

Oct 19th, 2015 - ORLANDO, Florida — Survival rates of the rare anaplastic thyroid carcinoma, which has a very poor prognosis, show significant improvement when patients are treated with an aggressive combined-modality therapy, although the toxicities associated wi...

Aggressive Approach to Anaplastic Thyroid Cancer Shows Benefit
https://www.staging.medscape.com/viewarticle/852901

Oct 19th, 2015 - ORLANDO, Florida — Survival rates of the rare anaplastic thyroid carcinoma, which has a very poor prognosis, show significant improvement when patients are treated with an aggressive combined-modality therapy, although the toxicities associated wi...

see more →